2020-12-01 11:38:12 RHHBY Roche
12/01/20 12/0111:38 12/01/2011:38 | Genentech receives FDA approval for Xolair for treatment of nasal polypsGenentech announced that the U.S. Food and Drug Administration has approved the company's supplemental Biologics License Application for Xolair for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids. Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this approval, Xolair is now the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E, a key driver of inflammation. The FDA's approval is based on results from the Phase III POLYP 1 and POLYP 2 trials. Both trials showed that adult patients with nasal polyps who had an inadequate response to nasal corticosteroids and received Xolair had statistically significant greater improvement from baseline at Week 24 in Nasal Polyp Score and weekly average Nasal Congestion Score than patients who received placebo. The greater improvements in NPS and NCS in the Xolair group compared to the placebo group were observed as early as the first assessment at Week 4 in both studies. All patients received background nasal mometasone therapy during both the treatment period and a five-week run-in period. In POLYP 1 and POLYP 2, the mean change from baseline at Week 24 for Xolair compared to placebo were: NPS, -1.1 versus 0.1 and -0.9 versus -0.3; NCS, -0.9 versus -0.4 and -0.7 versus -0.2. POLYP 1 and POLYP 2 are the ninth and tenth Phase III trials for Xolair, respectively. Results from POLYP 1 and POLYP 2 were recently published in the Journal of Allergy and Clinical Immunology. No new or unexpected safety signals were identified in patients treated with Xolair, with over 95% of patients completing each safety arm of POLYP 1 and POLYP 2. The most common adverse reactions included headache, injection site reaction, arthralgia, upper abdominal pain and dizziness. The safety profile in POLYP 1 and POLYP 2 was consistent with the established safety profile for Xolair. |
|
---|---|---|
|
Options
|
SunPower call volume above normal and directionally bullish »
13:45 01/22/21 01/2213:45 01/22/2113:45
SPWR
SunPower
Bullish option flow… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
CyberAgent initiated with a Neutral at Goldman Sachs »
13:43 01/22/21 01/2213:43 01/22/2113:43
CYAGF
CyberAgent
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
General news
| Oil Action: The weekly… Story temporarily locked. |
Hot Stocks
|
AIkido Pharma regains compliance with Nasdaq listing requirements »
13:32 01/22/21 01/2213:32 01/22/2113:32
AIKI
AIkido Pharma
AIkido Pharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Z Holdings initiated with a Buy at Goldman Sachs »
13:29 01/22/21 01/2213:29 01/22/2113:29
YAHOY
Z Holdings
Goldman Sachs analyst… Story temporarily locked. |
Recommendations
|
Bankinter price target raised to EUR 5.35 from EUR 5.25 at Deutsche Bank »
13:26 01/22/21 01/2213:26 01/22/2113:26
BKIMF
Bankinter
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Hargreaves Lansdown price target raised to 1,700 GBp at Deutsche Bank »
13:25 01/22/21 01/2213:25 01/22/2113:25
HRGLY
Hargreaves Lansdown
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Options
|
Camping World call volume above normal and directionally bullish »
13:25 01/22/21 01/2213:25 01/22/2113:25
CWH
Camping World
Bullish option flow… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
PSP Swiss Property price target raised to CHF 120 from CHF 103 at Deutsche Bank »
13:24 01/22/21 01/2213:24 01/22/2113:24
PSPSF
PSP Swiss Property
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Entain price target raised to 1,601 GBp from 1,351 GBp at Deutsche Bank »
13:22 01/22/21 01/2213:22 01/22/2113:22
GMVHF
Entain
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Commerzbank price target raised to EUR 6 from EUR 4 at Deutsche Bank »
13:22 01/22/21 01/2213:22 01/22/2113:22
CRZBY
Commerzbank
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Bristol-Myers announces approval of Opdivo plus Cabometyx for carcinoma »
13:21 01/22/21 01/2213:21 01/22/2113:21
BMY
Bristol-Myers
Bristol Myers Squibb… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
NASDAQ market internals summary »
13:17 01/22/21 01/2213:17 01/22/2113:17
$NSD
NASDAQ Market Internals
Volume is above average… Story temporarily locked. ShowHide Related Items >><<
|
Technical Analysis
|
NYSE market internals summary »
13:16 01/22/21 01/2213:16 01/22/2113:16
$NYE
NYSE Market Internals
Volume is above average… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Exelixis announces FDA approval of CABOMETYX in combination with OPDIVO »
13:12 01/22/21 01/2213:12 01/22/2113:12
EXEL
Exelixis
Exelixis announced that… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Baker Hughes reports U.S. rig count up 5 to 378 rigs »
13:11 01/22/21 01/2213:11 01/22/2113:11
BKR
Baker Hughes
Baker Hughes reports that… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Baker Hughes reports U.S. rig count up 5 to 378 rigs
13:01 01/22/21 01/2213:01 01/22/2113:01
BKR
Baker Hughes
ShowHide Related Items >><<
|
Upgrade
|
Icade upgraded to Buy from Hold at Deutsche Bank »
12:57 01/22/21 01/2212:57 01/22/2112:57
CDMGF
Icade
Deutsche Bank analyst… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Amazon files motion to halt union election at Alabama warehouse, Reuters says »
12:56 01/22/21 01/2212:56 01/22/2112:56
AMZN
Amazon.com
Amazon has filed a motion… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Sage Group price target lowered to 500 GBp from 530 GBp at Credit Suisse »
12:55 01/22/21 01/2212:55 01/22/2112:55
SGPYY
Sage Group
Credit Suisse analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
HelloFresh price target raised to EUR 81 from EUR 65 at Credit Suisse »
12:54 01/22/21 01/2212:54 01/22/2112:54
HLFFF
HelloFresh
Credit Suisse analyst… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Sandvik AB price target raised to SEK 240 from SEK 215 at Credit Suisse »
12:54 01/22/21 01/2212:54 01/22/2112:54
SDVKY
Sandvik AB
Credit Suisse analyst Max… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
| ShowHide Related Items >><<
|
Recommendations
|
Adidas price target raised to EUR 255 from EUR 250 at Credit Suisse »
12:50 01/22/21 01/2212:50 01/22/2112:50
ADDYY
Adidas
Credit Suisse analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Vuzix trading halted, volatility trading pause
12:48 01/22/21 01/2212:48 01/22/2112:48
VUZI
Vuzix
ShowHide Related Items >><<
|